VBL Therapeutics To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At

Press/Media: Press / Media

PeriodNov 13 2014

Media coverage

1

Media coverage

  • TitleVBL Therapeutics To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At
    Media name/outletBioSpace
    CountryUnited States
    Date11/13/14
    PersonsAndrew Brenner